home / stock / acxp / acxp news


ACXP News and Press, Acurx Pharmaceuticals Inc. From 12/08/23

Stock Information

Company Name: Acurx Pharmaceuticals Inc.
Stock Symbol: ACXP
Market: NASDAQ
Website: acurxpharma.com

Menu

ACXP ACXP Quote ACXP Short ACXP News ACXP Articles ACXP Message Board
Get ACXP Alerts

News, Short Squeeze, Breakout and More Instantly...

ACXP - New to The Street TV Features Five Corporate Guest Interviews, Episode 537 Airs on the FOX Business Network, Monday, December 11, 2023, at 10:30 PM PT

NEW YORK, Dec. 08, 2023 (GLOBE NEWSWIRE) -- FMW Media’s New to The Street , a nationally televised business show, announces episode 537, airing on the FOX Business Network on Monday, December 11, 2023, at 10:30 PM PT. New to The Street’s 537th episode f...

ACXP - New to The Street TV Announces Its Episode 536 Lineup, Five Corporate Guest Interviews, Broadcasted as Sponsored Program on Bloomberg TV, Tonight, Thursday, December 7, 2023, at 9:30 PM PT

NEW YORK, Dec. 07, 2023 (GLOBE NEWSWIRE) -- FMW Media's New to The Street announces its corporate interview lineup for its business show airing as a sponsored program on Bloomberg TV tonight, Thursday, December 7, 2023, at 9:30 PM PT. New to The Street's TV episode 536 ...

ACXP - New to The Street Announces Five Corporate Interviews, Episode 535, Airing on the FOX Business Network on Monday, December 4, 2023, at 10:30 PM PT

NEW YORK, Dec. 01, 2023 (GLOBE NEWSWIRE) -- New to The Street , an FMW Media business show production, will air episode 535 on the FOX Business Network , Monday, December 4, 2023, at 10:30 PM PT. New to The Street's episode 535 features the following five...

ACXP - New to The Street Announces its Five Business Guest Interviews, Episode 533, Airs on the FOX Business Network on Monday, November 27, 2023, at 10:30 PM PT

NEW YORK, Nov. 24, 2023 (GLOBE NEWSWIRE) -- FMW Media's New to The Street announces its feature lineup for its business show airing on the FOX Business Network on Monday, November 27, 2023, at 10:30 PM PT. New to The Street's TV episode 533 will air the following five (...

ACXP - New to The Street Announces Episode 530 with Six Corporate Interviews, Airing on the Fox Business Network, Monday, November 20, 2023, at 10:30 PM PT

NEW YORK, Nov. 17, 2023 (GLOBE NEWSWIRE) -- FMW Media's New to The Street announces the 530th episode lineup of its national business TV show, airing on Monday, November 20, 2023, at 10:30 PM PT on the Fox Business Network. The show features a new business segment, “The Bus...

ACXP - Lear Corporation declares $0.77 dividend

2023-11-14 16:38:18 ET More on etc. DSL: NAV Destruction Points To Struggles With The Distribution Acurx Pharmaceuticals, Inc. (ACXP) Q3 2023 Earnings Call Transcript USIG: The Time For Bonds Is Now Gold Royalty Non-GAAP EPS of -$0.01 in-line, revenue of $0.8...

ACXP - Acurx Pharmaceuticals, Inc. (ACXP) Q3 2023 Earnings Call Transcript

2023-11-14 16:28:03 ET Acurx Pharmaceuticals, Inc. (ACXP) Q3 2023 Earnings Conference Call November 14, 2023 08:00 AM ET Company Participants Robert Shawah - CFO David Luci - President & CEO Robert DeLuccia - Executive Chairman Conference Call Participa...

ACXP - Acurx Pharmaceuticals GAAP EPS of -$0.24

2023-11-14 07:23:11 ET More on Acurx Pharmaceuticals Acurx Undervalued And Set For Potential M&A With Next-Gen C. Diff Treatment Stocks To Watch: Tesla, Netflix, And AT&T Headline Big Week Of Earnings Acurx Pharma falls after mid-stage data for lead asset ...

ACXP - Acurx Pharmaceuticals, Inc. Reports Third Quarter 2023 Results and Provides Business Update

Acurx Pharmaceuticals, Inc. Reports Third Quarter 2023 Results and Provides Business Update PR Newswire STATEN ISLAND, N.Y. , Nov. 14, 2023 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical c...

ACXP - Expected US Company Earnings on Tuesday, November 14th, 2023

Laser Photonics Corporation (LASE) is expected to report for Q2 2024 QuickLogic Corporation (QUIK) is expected to report $0.08 for Q3 2023 Stryve Foods Inc. (SNAX) is expected to report $-1.65 for Q3 2023 Reata Pharmaceuticals Inc. (RETA) is expected to report $-2.15 for Q3 2023 V...

Previous 10 Next 10